Postgrad Med J

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sooriakumaran, P
Right arrow Articles by Pierro, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sooriakumaran, P
Right arrow Articles by Pierro, A
Postgraduate Medical Journal 2005;81:259-261
© 2005 Fellowship of Postgraduate Medicine


ORIGINAL ARTICLE

Peritoneovenous shunting is an effective treatment for intractable ascites

P Sooriakumaran , H F McAndrew , E M Kiely , L Spitz , A Pierro

Great Ormond Street Hospital for Children, London, UK

Correspondence to:
Correspondence to:
Dr P Sooriakumaran
Flat 15 Andhurst Court, 2A Coombe Lane West, Kingston, Surrey KT2 7DX, UK; p.s{at}doctors.org.uk

Aim and methods: A retrospective review was carried out of children undergoing peritoneovenous shunting for intractable ascites.

Results: 11 children, aged 3 months to 12 years (median 31 months) underwent peritoneovenous shunting over the past 17 years. The duration of ascites ranged from one month to 2.5 years (median two months). The primary pathology consisted of previous surgery in eight (three neuroblastoma, one renal carcinoma, one hepatoblastoma, one adrenal teratoma, one renal artery stenosis, and one diaphragmatic hernia), and cytomegalovirus hepatitis, lymphatic hypoplasia, and lymphohistiocytosis in one patient each. All patients had failed to respond to previous treatment including peritoneal drainage in six patients, diuretics in five, and parenteral nutrition in five. There were no intraoperative problems. Postoperative complications included pulmonary oedema in three patients, shunt occlusion in three, infection in two, and wound leakage in one. Ascites resolved after shunting in 10 patients. Five shunts were removed one to three years after insertion without recurrence of ascites. Three others are free of ascites with shunts in place for less than one year postoperatively. Three children died from their underlying disease: two after resolution of ascites (neuroblastoma) and one in whom the ascites failed to resolve (lymphohisticytosis).

Conclusions: Peritoneovenous shunting is an effective treatment for symptomatic intractable ascites in children (10 of 11 successful cases in this series). Elective removal of the shunt after one year is recommended.


Keywords: peritoneovenous shunting; ascites







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 The Fellowship of Postgraduate Medicine